CEL-SCI Presentation at LD Micro "Main Event" Available on Tuesday, October 21, 2025 Nanotech Investing
Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology Nanotech Investing
Sona Nanotech Reports 80% Response Rate in First-In-Human THT Cancer Therapy Study Nanotech Investing
Rani Therapeutics Announces Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules Nanotech Investing
Rani Therapeutics Announces up to $1.085 Billion Collaboration with Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including Rare Disease and Immunology Programs and Announces Concurrent Oversubscribed $60.3 Million Financing Nanotech Investing
MIMEDX to Host Third Quarter 2025 Operating and Financial Results Conference Call on October 29 Nanotech Investing
Soleno Therapeutics Appoints Biopharmaceutical Executive Mark W. Hahn to its Board of Directors Nanotech Investing
Qualigen Therapeutics Announces the Official Launch of C10 Cryptocurrency Asset Treasury Purchases: Why Is This Pullback the Golden Moment CXC10 Has Been Waiting For? Nanotech Investing
Taiho Oncology and Cullinan Therapeutics Present Data on Zipalertinib in Patients with NSCLC with EGFR mutations and Active Brain Metastases at the ESMO Congress 2025 Nanotech Investing
Satellos Announces New Data Further Demonstrating Safety, Tolerability, and Functional Impact of SAT-3247 in First-in-Human Trial of Adults with Duchenne Muscular Dystrophy Nanotech Investing
